291
Views
15
CrossRef citations to date
0
Altmetric
A NEW THERAPEUTIC OPTION FOR NASOPHARYNGEAL CARCINOMA

Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy

, , &
Pages 853-858 | Received 18 Sep 2013, Accepted 31 Mar 2014, Published online: 25 Jun 2014

References

  • Asin L, Goya GF, Tres A, Ibarra MR. 2013. Induced cell toxicity originates dendritic cell death following magnetic hyperthermia treatment. Cell Death Dis 4:e596.
  • Braam PM, Roesink JM, Raaijmakers CP, Busschers WB, Terhaard CH. 2007. Quality of life and salivary output in patients with head- and-neck cancer five years after radiotherapy. Radiat Oncol 2: 3.
  • Cao SM, Simons MJ, Qian CN. 2011. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 30:114–118.
  • Chan ATC. 2010. Nasopharyngeal carcinoma. Annals Oncol 21:308–312.
  • Chan AT, Teo PM, Johnson PJ. 2002. Nasopharyngeal carcinoma. Annals Oncol 13:1007–1015.
  • Chan YW, Chow VL, Wei WI. 2012. Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Cancer 8:3710–3718.
  • Fareed MM, AlAmro AS, Bayoumi Y, Tunio MA, Ismail AS, Akasha R, Mubasher M, Al Asiri M. 2013. Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma BMC Cancer 13:318.
  • Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC, Liao XY, Chen QS. 2010. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer 29:153–158.
  • Hernández-Bule ML, Roldán E, Matilla J, Trillo MA, Ubeda A. 2012. Radiofrequency currents exert cytotoxic effects in NB69 human neuroblastoma cells but not in peripheral blood mononuclear cells. Int J Oncol 41:1251–1259.
  • Hua Y, Ma S, Fu Z, Hu Q, Wang L, Piao Y. 2011. Intraccavity hyperthermia in nasopharyngeal cancer: A phase III clinical study. Int J Hypertherm 27:180–186.
  • Huilgol NG, Gupta S, Dixit R. 2010. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia 26: 21–25.
  • Hulshof MC, Van Haaren PM, Van Lanschot JJ, Richel DJ, Fockens P, Oldenborg S, Geijsen ED, Van Berge Henegouwen MI, Crezee J. 2009. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer. Int J Hypertherm 25:79–85.
  • Jones EL, Prosnitz LR, Dewhirst MW, Marcom PK, Har denbergh PH, Marks LB, Brizel DM, Vujaskovic Z. 2004. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 10:4287–4293.
  • Keereweer S, Kerrebijn JD, Al-Mamgani A, Sewnaik A, Baatenburg de Jong RJ, Van Meerten E. 2012. Chemoradiation for advanced hypopharyngeal carcinoma: A retrospective study on efficacy, morbidity and quality of life. Eur Arch Otorhinolaryngol 269:939–946.
  • Leung SW, Lee TF. 2013. Treatment of nasopharyngeal carcinoma by tomotherapy: Five-year experience. Radiat Oncol 8:107.
  • Li XH, Rong PF, Jin HK, Wang W, Tang JT. 2012. Magnetic fluid hyperthermia induced by radiofrequency capacitive field for the treatment of transplanted subcutaneous tumors in rats. Exp Ther Med 3:279–284.
  • Ma BB, Chan AT. 2005. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103:22–31.
  • Ostapenko VV, Tanaka H, Miyano M, Nishide T, Ueda H, Nishide I, Tanaka Y, Mune M, Yukawa S. 2005. Immune-related effects of local hyperthermia in patients with primary liver cancer. Hepatogastroenterology 52:1502–1506.
  • Raoof M, Curley SA. 2011. Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma. Int J Hepatol 2011:676957.
  • Raoof M, Cisneros BT, Corr SJ, Palalon F, Curley SA, Koshkina NV. 2013. Tumor selective hyperthermia induced by short-wave capacitively-coupled RF electric-fields. PLoS One 8:e68506.
  • Shueng PW, Shen BJ, Wu LJ, Liao LJ, Hsiao CH, Lin YC, Cheng PW, Lo WC, Jen YM, Hsieh CH. 2011. Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma. Radiat Oncol 6:95
  • Song CW, Shakil A, Osborn JL, Iwata K. 1996. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hypertherm 12:367–373.
  • Suárez C, Rodrigo JP, Rinaldo A, Langendijk JA, Shaha AR, Ferlito A. 2010. Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol 267:1811–1824.
  • Sun Y, Tang LL, Chen L, Li WF, Mao YP, Liu LZ, Lin AH, Li L, Ma J. 2012. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system. BMC Cancer 12:68.
  • Xiao JP, Xu GZ. 2010. Stereotactic radiotherapy – an approach to improve local control of nasopharyngeal carcinoma. Chin J Cancer 29:123–125.
  • Xiao WW, Huang SM, Han F, Wu SX, Lu LX, Lin CG, Deng XW, Lu TX, Cui NJ, Zhao C. 2011. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy. Cancer 117:1874–1883.
  • Zhao C, Dai C, Chen XY. 2012. Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer. Int J Hypertherm 28:735–741.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.